Scott Patterson

Scott Patterson, ILC Dover - Qepler Summits And Conferences

Scott Patterson

Vice President Pharma/BioPharma Technical Support
ILC Dover
Chicago, USA
ILC Dover is a world leader in the innovative design and manufacturer of engineered products employing high-performance flexible materials to aerospace, medical and inflatables markets.

Scott Patterson is the Vice President of Commercial Sales with ILC Dover, a diversified manufacturing company that provides engineered products to a range of markets from aerospace to pharmaceutical manufacturing.

He has been with ILC Dover for 13 years working in the global pharmaceutical market for high containment solutions.

Prior to the current assignment he was in executive management for capital equipment suppliers including milling, roll compaction, metal detection and x-ray systems. He is active with multiple industry groups promoting containment technology with an emphasis on flexible single use systems that achieve nanogram level containment.

Related Sessions:

Qepler - Highly Potent APIs Summit thumbnail Details

Highly Potent APIs
Summit 2019

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 20 Feb 2019
  • Berlin, DE
  • Pharma
Day 1: Wednesday, 20 February 2019
BLOCK: PROCESS ROBUSTNESS, SAFETY & EFFICIENCY.
CASE STUDY: Single Use Flexible Isolators reduces cleaning and cross contamination risk.
  • Introduction of single use flexible isolators and containment performance Ergonomic benefits when using flexible isolators and other single use technology Disposal of the single use vs. cleaning - risk reduction Disposal of the single use vs. cleaning - cost reduction.
  • Using a single use flexible isolator provides cost savings and reduces risk of cross contamination from retention. This is very important with HPAPI and cleaning limits being reduced.
View Details
Qepler - 2nd Annual Highly Potent APIs Summit thumbnail Details

2nd Annual Highly Potent APIs
Summit 2020

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 19 Feb 2020
  • Prague, CZ
  • Pharma
Day 1: Wednesday, 19 February 2020
CASE STUDY: Versatility when implementing Flexible Containment Systems for HPAPI handling.

In this presentation the benefits of using flexible containment systems are discussed. The benefits explored will include ergonomics, retrofitting of existing equipment, adaptability for process changes, and ownership costs. Flexible isolator systems will be presented along with powder transfer technology. Performance data will also be discussed to demonstrate the value of flexible containment systems includes the ability to meet nanogram level containment.

View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.